The Provider Score for the Prostate Cancer Score in 17102, Harrisburg, Pennsylvania is 96 when comparing 34,000 ZIP Codes in the United States.
An estimate of 91.98 percent of the residents in 17102 has some form of health insurance. 38.14 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 64.83 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 17102 have VA health insurance. Also, percent of the residents receive TRICARE.
For the 939 residents under the age of 18, there is an estimate of 61 pediatricians in a 20-mile radius of 17102. An estimate of 2 geriatricians or physicians who focus on the elderly who can serve the 1,033 residents over the age of 65 years.
In a 20-mile radius, there are 19,638 health care providers accessible to residents in 17102, Harrisburg, Pennsylvania.
Health Scores in 17102, Harrisburg, Pennsylvania
Prostate Cancer Score | 83 |
---|---|
People Score | 17 |
Provider Score | 96 |
Hospital Score | 61 |
Travel Score | 71 |
17102 | Harrisburg | Pennsylvania | |
---|---|---|---|
Providers per 10,000 residents | 0.00 | 0.00 | 0.00 |
Pediatricians per 10,000 residents under 18 | 0.00 | 0.00 | 0.00 |
Geriatricians per 10,000 residents over 65 | 0.00 | 0.00 | 0.00 |
## Prostate Cancer Score: Harrisburg, PA (ZIP Code 17102) – An Analysis
This analysis delves into the landscape of prostate cancer care within Harrisburg, Pennsylvania, specifically focusing on the 17102 ZIP code. We'll assess the availability of primary care physicians, the quality of care, the adoption of telemedicine, and the accessibility of mental health resources, all critical components in a patient's journey through prostate cancer diagnosis and treatment. This comprehensive evaluation aims to provide a “Prostate Cancer Score” assessment, offering insights for residents and healthcare providers alike.
The foundation of effective prostate cancer care rests on accessible and responsive primary care. In Harrisburg's 17102, understanding the physician-to-patient ratio is paramount. A low ratio, indicating fewer doctors for a larger population, can translate to longer wait times for appointments, potentially delaying crucial screenings and early detection. Conversely, a higher ratio suggests greater accessibility. Data from the Pennsylvania Department of Health, combined with information from local healthcare networks like UPMC and Penn State Health, would provide the most accurate picture. This data would need to be analyzed to determine the current physician-to-patient ratio, comparing it to state and national averages to gauge the relative ease of access to primary care within the ZIP code. This initial assessment forms the bedrock of our score.
Beyond sheer numbers, the quality of primary care significantly impacts prostate cancer outcomes. Practices that emphasize preventative care, including routine prostate-specific antigen (PSA) testing for men over 50 (or earlier for those with risk factors), are crucial. A detailed review of practices in 17102 would involve examining their commitment to early detection. This includes looking at the percentage of patients screened annually, the protocols for follow-up testing after an elevated PSA result, and the referral pathways to urologists and oncologists. Practices demonstrating a proactive approach to screening and early intervention would score higher in this evaluation.
Identifying standout practices within the 17102 area is a key element of this analysis. These practices would be characterized by a patient-centered approach, incorporating elements such as extended hours, ease of appointment scheduling (online booking), and clear communication with patients. They would also demonstrate a commitment to evidence-based medicine, adhering to the latest guidelines for prostate cancer screening, diagnosis, and management. Reviews from patients, accessible through platforms like Healthgrades or Zocdoc, would be crucial in assessing the overall patient experience and identifying practices that consistently deliver high-quality care.
The adoption of telemedicine is transforming healthcare delivery, and its presence within 17102 is a significant factor in our scoring. Telemedicine offers several advantages for prostate cancer patients, particularly those with mobility limitations or those residing in areas with limited access to specialists. Virtual consultations for follow-up appointments, medication management, and even initial consultations can significantly improve convenience and reduce the burden on patients. Practices that have embraced telemedicine, providing virtual appointments for primary care and specialist consultations, would receive higher scores. We would examine the availability of virtual visits, the platforms used, and the ease of access for patients.
The emotional and psychological impact of a prostate cancer diagnosis and treatment cannot be overstated. Access to mental health resources is a critical component of comprehensive care. This analysis would assess the availability of mental health services within 17102, focusing on the presence of therapists, counselors, and support groups specializing in oncology. The proximity of these resources, their acceptance of insurance, and the availability of virtual mental health services would all be considered. Practices that actively integrate mental health support into their patient care model, offering referrals to qualified professionals and promoting mental well-being, would receive higher scores. The availability of support groups specifically for prostate cancer patients and their families is another important factor.
The “Prostate Cancer Score” is not a static number; it is a dynamic assessment that reflects the evolving healthcare landscape. This analysis would consider the integration of advanced technologies, such as artificial intelligence (AI) in diagnostic imaging, as well as the use of minimally invasive surgical techniques. Practices that are at the forefront of innovation, adopting these technologies to improve patient outcomes, would be recognized. The presence of a multidisciplinary team, including urologists, oncologists, radiation oncologists, and nurses specializing in prostate cancer care, is also critical.
The data gathered and analyzed for this report would be sourced from multiple locations. Public health databases, physician directories, insurance provider websites, and patient review platforms would be utilized. This information would be carefully vetted to ensure accuracy and reliability. The final score would be a composite of several factors, weighted based on their relative importance in patient care. The final product would reflect a comprehensive assessment of the quality of prostate cancer care in the 17102 ZIP code.
The final score would be presented in a clear and concise format, highlighting the strengths and weaknesses of the healthcare landscape. This information would be invaluable to residents of 17102, empowering them to make informed decisions about their healthcare. It would also provide valuable insights for healthcare providers, allowing them to identify areas for improvement and enhance the quality of care they deliver. The goal is to improve the overall experience for patients dealing with prostate cancer.
For a visual representation of this data, including a geographic analysis of physician locations, practice characteristics, and resource accessibility, we recommend exploring the interactive mapping capabilities offered by CartoChrome. CartoChrome's maps can provide a powerful visual tool for understanding the healthcare landscape in Harrisburg and beyond.
Reviews
No reviews yet.
You may also like